Manuscripts

Search by keyword, year, or author name.

Showing 1554 manuscripts.

Neurologic manifestations of human immunodeficiency virus infections

Karl Kieburtz, Randolph B. Schiffer. Neurologic manifestations of human immunodeficiency virus infections. Neurologic Clinics. 1989. 7: 447-68.

Year

1989

Journal

Neurologic Clinics

Recovery of human immunodeficiency virus and detection of p24 antigen in bronchoalveolar lavage fluid from adult patients with AIDS

Calvin C. Linnemann, Robert Baughman, Peter T. Frame, R. Floyd. Recovery of human immunodeficiency virus and detection of p24 antigen in bronchoalveolar lavage fluid from adult patients with AIDS. Chest. 1989. 96: 64-7.

Year

1989

Journal

Chest

Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications

Kristine L. MacDonald, Brooks Jackson, R. J. Bowman, H. F. Polesky, Frank S. Rhame, Henry H. Balfour, M. T. Osterholm. Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications. Annals of Internal Medicine. 1989. 110: 617-21.

Year

1989

Journal

Annals of Internal Medicine

T cells expressing high levels of non-major histocompatibility complex (MHC)-restricted cytotoxicity are present in early and late clinical phases of human immunodeficiency virus 1 (HIV-1) infection

Jane E. Morgan, Carolyn B. Daul, Richard D. DeShazo, W. Abe Andes, Newton E. Hyslop. T cells expressing high levels of non-major histocompatibility complex (MHC)-restricted cytotoxicity are present in early and late clinical phases of human immunodeficiency virus 1 (HIV-1) infection. Journal of Clinical Immunology. 1989. 9: 97-102.

Year

1989

Journal

Journal of Clinical Immunology

Human immunodeficiency virus-associated autoimmune thrombocytopenic purpura: a review

Lee Ratner. Human immunodeficiency virus-associated autoimmune thrombocytopenic purpura: a review. American Journal of Medicine. 1989. 86: 194-8.

Year

1989

Journal

American Journal of Medicine

The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker

Stephen A. Spector, C. Kennedy, J. Allen McCutchan, Sam Bozzette, R. G. Straube, James D. Connor, Douglas D. Richman. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. Journal of Infectious Diseases. 1989. 159: 822-8.

Year

1989

Journal

Journal of Infectious Diseases

Monitoring of AZT

Brian Stretcher. Monitoring of AZT. Clinical Chemistry. 1989. 11: 9-16.

Year

1989

Journal

Clinical Chemistry

Antibody specificity for human immunodeficiency virus type 1 in serum and cerebrospinal fluid from patients with AIDS and AIDS-related complex

P. Willoughby, J. S. Midgett, James D. Folds. Antibody specificity for human immunodeficiency virus type 1 in serum and cerebrospinal fluid from patients with AIDS and AIDS-related complex. European Journal of Clinical Microbiology and Infectious Diseases. 1989. 8: 1031-7.

Year

1989

Journal

European Journal of Clinical Microbiology and Infectious Diseases

A pilot study of diethyldithiocarbamate in patients with acquired immune deficiency syndrome (AIDS) and the AIDS-related complex

Gary Brewton, E. M. Hersh, A. Rios, Peter Mansell, F. Blaine Hollinger, James M. Reuben. A pilot study of diethyldithiocarbamate in patients with acquired immune deficiency syndrome (AIDS) and the AIDS-related complex. Life Sciences. 1989. 45: 2509-20.

Year

1989

Journal

Life Sciences

Biochemical pharmacology of zidovudine in human T-lymphoblastoid cells (CEM)

Vassilios I. Avramis, W. Markson, Randy L. Jackson, Edward Gomperts. Biochemical pharmacology of zidovudine in human T-lymphoblastoid cells (CEM). AIDS. 1989. 3: 417-22.

Year

1989

Journal

AIDS